semaglutide launch title Today we launch, Obeda®, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Alkem Launches India's First Single-Shot

(Novo Nordisk ended their savings program for Saxenda as of June 30, 2023.) Eli Lilly, the maker of Mounjaro, offers a similar savings card that can bring the cost down to as low as $25 for a monthly supply

Some ingredient suppliers market fermented or specialized versions of the extract for anti-aging purposes

I went back on metformin in April

More Peptide, Less Waste: Bypassing the gut means more of your peptide gets to where its needed

In pivotal trials, weekly semaglutide produced roughly 1415% body-weight reduction at 68 weeks (STEP 1, NEJM 2021), and tirzepatide a dual GIP/GLP-1 co-agonist reached 1822% at one year (SURMOUNT-1, NEJM 2022)

By correcting conditions like megaloblastic anemia, these injections ensure your body has plenty of healthy red blood cells to carry oxygen where it needs to go